FIELD: medicine.
SUBSTANCE: treatment and prevention of diseases of the upper respiratory tract. Artificial nasal secretion for correction of the microflora of the nasal mucosa contains sodium hyaluronate (powder) 1.0 mg per 1 ml, lysozyme hydrochloride (powder) 2.5 mg per 1 ml, lactoferrin (powder) 5.0 mg per 1 ml, lyophilisate probiotic microorganisms Streptococcus salivarius K12 not less than 107 CFU per 1 ml.
EFFECT: correction of the microflora of the mucous membrane of the nasal cavity and nasopharynx, increase of local immunity of the mucous membrane of the upper respiratory tract.
2 cl, 3 ex
Authors
Dates
2023-07-18—Published
2022-09-13—Filed